Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report

被引：2
|
作者：
Kim, Jin Hae [1 ]
Kim, Ji Won [1 ]
Kim, Young Nam [1 ]
Kim, Hye In [1 ]
Kim, Jun Young [1 ]
Kwon, Ghee Young [3 ]
Kim, Kihyun [4 ]
Jang, Hye Ryoun [2 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Nephrol, 81 Irwon Ro, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
CASE REPORTS IN NEPHROLOGY AND DIALYSIS | 2015年 / 5卷 / 03期
关键词：
Multiple myeloma; Monoclonal gammopathy of undetermined significance; Proteinuria;
D O I：
10.1159/000439267
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Monoclonal gammopathy with undetermined significance (MGUS) carries a risk of progression to multiple myeloma, and progression is usually diagnosed with changes in M-protein or bone marrow biopsy. We report a case of 62-year-old female patient showing MGUS progression to multiple myeloma without significant changes in M-protein but diagnosed by kidney biopsy. During the follow-ups, azotemia and tubular proteinuria were aggravated without elevation of M-protein. Kidney biopsy showed intratubular and glomerular inclusions associated with plasma cell dysplasia. The progression of MGUS to multiple myeloma was diagnosed by this kidney biopsy. The patient's renal function and tubular proteinuria were markedly improved after chemotherapy. (C) 2015 S. Karger AG, Basel
引用
收藏
页码：180 / 186
页数：7
相关论文
共 50 条
  • [41] Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
    Rajkumar, S. Vincent
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5606 - 5608
  • [42] Pathogenesis and progression of monoclonal gammopathy of undetermined significance
    J Bladé
    L Rosiñol
    M T Cibeira
    C F de Larrea
    Leukemia, 2008, 22 : 1651 - 1657
  • [43] Genomic aberrations in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) and the risk of progression to multiple myeloma (MM)
    Van Wier, S. A.
    Larson, D. M.
    Chng, W.
    Rempel, R.
    Ahmann, G. J.
    Henderson, K. M.
    Figueroa, G.
    Kyle, R. A.
    Rajkumar, S. V.
    Dispenzieri, A. D.
    Bersagel, P. L.
    Stewart, A. K.
    Therneau, T. M.
    Greipp, P. R.
    Fonseca, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 99 - 99
  • [44] Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
    Tahiru, Widad
    Izarra Santamaria, Antonio
    Hultdin, Johan
    Wu, Wendy Yi-Ying
    Spath, Florentin
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [45] The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
    Liu, Lawrence
    Grandhi, Nikhil
    Wang, Mei
    Thomas, Theodore S.
    Kumar, Akhil
    Vargo, Kristin
    Sanfilippo, Kristen M.
    Colditz, Graham A.
    Chang, Su-Hsin
    BLOOD, 2022, 140 : 4283 - 4284
  • [46] Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites
    Greenberg, A. J.
    Vachon, C. M.
    Rajkumar, S. V.
    LEUKEMIA, 2012, 26 (04) : 609 - 614
  • [47] Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma
    Bogun, Lucienne
    Koch, Annemarie
    Scherer, Bo
    Fenk, Roland
    Maus, Uwe
    Bormann, Felix
    Koehrer, Karl
    Petzsch, Patrick
    Wachtmeister, Thorsten
    Zukovs, Romans
    Dietrich, Sascha
    Haas, Rainer
    Schroeder, Thomas
    Jaeger, Paul
    Geyh, Stefanie
    BLOOD ADVANCES, 2024, 8 (10) : 2575 - 2588
  • [48] Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
    Thordardottir, Marianna
    Lindqvist, Ebba K.
    Lund, Sigrun H.
    Costello, Rene
    Burton, Debra
    Korde, Neha
    Mailankody, Sham
    Eiriksdottir, Gudny
    Launer, Lenore J.
    Gudnason, Vilmundur
    Harris, Tamara B.
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD ADVANCES, 2017, 1 (24) : 2186 - 2192
  • [49] Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
    Widad Tahiru
    Antonio Izarra Santamaria
    Johan Hultdin
    Wendy Yi-Ying Wu
    Florentin Späth
    Experimental Hematology & Oncology, 11
  • [50] Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites
    A J Greenberg
    C M Vachon
    S V Rajkumar
    Leukemia, 2012, 26 : 609 - 614
12345